awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37211774-D097AC43-C6D9-425A-A51B-4FAD06833297
Q37211774-D097AC43-C6D9-425A-A51B-4FAD06833297
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37211774-D097AC43-C6D9-425A-A51B-4FAD06833297
RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma.
P2860
Q37211774-D097AC43-C6D9-425A-A51B-4FAD06833297
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37211774-D097AC43-C6D9-425A-A51B-4FAD06833297
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
268b49729111407984da6c5e90af52627846f58a
P2860
Rationale and design of decision: a double-blind, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of sorafenib in patients with locally advanced or metastatic radioactive iodine (RAI)-refractory, differentiated thyr